This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters To the Editor

Reply to Use of Olanzapine in Anorexia Nervosa

Nicole C. Barbarich-Marsteller, BS, and Walter H. Kaye, MD

Published: May 15, 2005

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: In response to the letter to the editor "Use of Olanzapinein Anorexia Nervosa," we would like to address the author’s criticisms. We appreciate the author’s concerns and interest inimproving treatment for anorexia nervosa.It is well known that individuals with anorexia nervosa areinherently difficult to treat, even in an inpatient setting.’ ‹’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 66

Quick Links: Psychiatry

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...